Urologic Diseases: Clinical Trials

19,198 trials for Urologic Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9971 completed, 2885 unknown, 2214 recruiting, 1469 terminated. 5871 Not applicable, 3427 Phase 2, 2293 Phase 1, 1812 Phase 3, 1516 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable5871Completed 2982, Unknown 983, Recruiting 721, Not yet recruiting 365, Terminated 348, Active not recruiting 214, Withdrawn 189, Enrolling by invitation 55, Suspended 14
Phase 23427Completed 1716, Terminated 466, Recruiting 407, Unknown 351, Active not recruiting 192, Withdrawn 147, Not yet recruiting 126, Suspended 12, Enrolling by invitation 10
Phase 12293Completed 1305, Recruiting 271, Terminated 249, Unknown 167, Active not recruiting 136, Withdrawn 78, Not yet recruiting 73, Suspended 9, Enrolling by invitation 5
Phase 31812Completed 1016, Terminated 204, Unknown 199, Recruiting 163, Active not recruiting 95, Withdrawn 78, Not yet recruiting 48, Enrolling by invitation 5, Suspended 4
Phase 41516Completed 801, Unknown 288, Terminated 146, Recruiting 111, Withdrawn 74, Not yet recruiting 53, Active not recruiting 31, Enrolling by invitation 6, Suspended 6
Early Phase 1200Completed 83, Recruiting 31, Unknown 27, Not yet recruiting 20, Terminated 13, Withdrawn 10, Active not recruiting 9, Enrolling by invitation 5, Suspended 2

Follow Urologic Diseases: new trials by email Literature Review of Urologic Diseases trials Research Report on Urologic Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Maastricht Investigation of Renal Function in Absence of- and Post- Contrast in Patients With eGFR LEss Than 30
serum creatinine assay - Acute Kidney Injury (Nontraumatic), Contrast-induced Nephropathy
WithdrawnMaastricht University Medical Center2097-11-012023-10-19
Time to Excretion of Contrast, a Maastricht Prospective Observational Study
Contrast concentration in urine - Renal Insufficiency, Acute Kidney Injury
WithdrawnMaastricht University Medical Center2097-11-012023-10-19
Efficacy of Point-Of-Care Creatinine Assays in Patients With eGFR <30 Receiving Intravascular Contrast
serum creatinine assay - Renal Insufficiency, Acute Kidney Injury
WithdrawnMaastricht University Medical Center2097-05-012023-10-19
Evaluation of Naloxegol in the Prevention of POI After Cystectomy
Naloxégol oxalate, Placebo oral tablet - Bladder Cancer, Cystostomy; Complications
Phase 2WithdrawnInstitut Paoli-Calmettes2032-01-012026-10-14
Antibiotics for Kidney Transplant Recipients
Trimethoprim-Sulfamethoxazole (TMP-SMX), Usual Care - Kidney Transplant, Urinary Tract Infection(UTI)
Phase 4Not yet recruitingUniversity of California, San Francisco502028-10-012026-09-11
Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder Cancer
AI Uro-Cam - Bladder Cancer
Not applicableNot yet recruitingChinese University of Hong Kong602028-07-312026-07-22
MRI Technical Development and Applications in Kidney Disease
Chronic Kidney Diseases, Kidney Transplantation
Not yet recruitingUniversity of Minnesota1802028-06-302026-04-13
Device for Bladder Control for Men With SCI
Noninvasive electrical stimulation device to improve bladder control - Neurogenic Bladder
Phase 1 / Phase 2Not yet recruitingVA Office of Research and Development122028-06-012026-06-25
Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)
NM8074 - IgA Nephropathy
Phase 2Not yet recruitingNovelMed Therapeutics102028-02-012026-04-13
School-Based Bladder Health Intervention
Bladder Health Education - Urinary Dysfunction, Lower Urinary Tract Symptoms
Not applicableWithdrawnStanford University2028-01-012026-05-07
Precision-Medicine Diagnostic Support in Hospitalized Veterans With Acute Kidney Injury
PRECISE-AKI Clinical Decision Support Tool - Acute Kidney Injury (AKI)
Not applicableNot yet recruitingVA Office of Research and Development602028-01-012025-10-16
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients With Refractory Systemic Lupus Erythematosus (GALLOP)
CB-010 - Systemic Lupus Erythematosus, Lupus
Phase 1WithdrawnCaribou Biosciences, Inc.2027-12-012025-09-19
Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy
NM8074 - aHUS - Atypical Hemolytic Uremic Syndrome
Phase 2Not yet recruitingNovelMed Therapeutics122027-11-012026-04-13
Veteran Centered Meal Intervention in Chronic Kidney Disease
Medically tailored meals (MTMs) - Chronic Kidney Disease
Not applicableNot yet recruitingVA Office of Research and Development1002027-10-012026-09-03
Amino Acid Therapy Evaluating the Incidence of New-Onset AKI
Amino Acid infusion, Lactated Ringer Solution - Acute Kidney Injury
Phase 2Not yet recruitingChildren's Hospital Medical Center, Cincinnati2702027-10-012026-10-21
Technology-enabled Social Network Intervention to Increase Live Donor Kidney Transplantation
Digital education outreach intervention for kidney transplant access and human guide, Digital education outreach intervention for kidney transplant access only (unguided) - End-Stage Renal Disease, Chronic Kidney Diseases
Not applicableNot yet recruitingState University of New York at Buffalo5502027-10-012026-10-20
Anti-Interleukin-6 (IL6) in Calciphylaxis
Tocilizumab - Calciphylaxis
Phase 1Not yet recruitingBoston Medical Center102027-09-012026-07-16
Empowerment Program to Reduce Treatment of Asymptomatic Bacteriuria in Veterans With Spinal Cord Injury
Empowerment Program - Spinal Cord Injury, Spinal Cord Disease
Not applicableNot yet recruitingVA Office of Research and Development302027-08-022026-08-19
A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases
CD19-targeted iNKT Cell Injection - IgA Nephropathy (IgAN), Membranous Nephropathy
Early Phase 1Not yet recruitingGrit Biotechnology302027-08-012026-09-11
Trial Without Borders IMPLEMENT-CKD: IMPLEMENTation of Evidence-Based SGLT2i to Reduce Global Burden of Cardiovascular and Chronic Kidney Disease
Implementation of recommendations - Implementation Research, Kidney Disease
Not yet recruitingThe University of Queensland13902027-07-012026-10-02

Showing 20 of 19198. Sign in to see all of them.

Narrower conditions

Renal Insufficiency, Chronic (3073)  ·  Kidney Failure, Chronic (1997)  ·  Carcinoma, Renal Cell (1956)  ·  Urinary Bladder Neoplasms (1723)  ·  Acute Kidney Injury (1617)  ·  Renal Insufficiency (1370)  ·  Kidney Diseases (966)  ·  Kidney Neoplasms (956)  ·  Urinary Incontinence (934)  ·  Urinary Bladder, Overactive (802)  ·  Urinary Tract Infections (719)  ·  Urinary Incontinence, Stress (642)  ·  Diabetic Nephropathies (515)  ·  Kidney Calculi (501)  ·  Neoplasms (481)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (19195)  ·  Female Urogenital Diseases (19188)  ·  Male Urogenital Diseases (19181)  ·  Urogenital Diseases (19171)  ·  Kidney Diseases (12291)  ·  Pathological Conditions, Signs and Symptoms (10006)  ·  Pathologic Processes (6379)  ·  Renal Insufficiency (5947)  ·  Disease Attributes (5252)  ·  Chronic Disease (4867)  ·  Neoplasms by Site (4476)  ·  Urogenital Neoplasms (4394)  ·  Neoplasms (4220)  ·  Urologic Neoplasms (4193)

Interventions

pembrolizumab (227)  ·  Gemcitabine (214)  ·  Nivolumab (191)  ·  Sunitinib (163)  ·  Blood Specimen Collection (152)  ·  Cyclophosphamide (149)  ·  Mycophenolic Acid (137)  ·  Cisplatin (134)  ·  Tacrolimus (124)  ·  Saline Solution (123)  ·  Standard of Care (121)  ·  Everolimus (111)  ·  Solifenacin Succinate (107)  ·  Magnetic Resonance Spectroscopy (105)  ·  Sodium Chloride (104)

Sponsors

National Cancer Institute (NCI) (240)  ·  Assiut University (206)  ·  Pfizer (173)  ·  Mayo Clinic (136)  ·  Novartis Pharmaceuticals (132)  ·  AstraZeneca (131)  ·  Bayer (126)  ·  Assistance Publique - Hôpitaux de Paris (123)  ·  M.D. Anderson Cancer Center (106)  ·  National Taiwan University Hospital (103)  ·  Ain Shams University (99)  ·  Seoul National University Hospital (99)  ·  Mansoura University (97)  ·  Memorial Sloan Kettering Cancer Center (94)  ·  Amgen (93)

Countries

United States (6989)  ·  China (1625)  ·  France (1550)  ·  Canada (1260)  ·  Germany (1101)  ·  United Kingdom (1100)  ·  Italy (1020)  ·  Spain (955)  ·  Turkey (Türkiye) (760)  ·  South Korea (734)  ·  Netherlands (606)  ·  Egypt (597)  ·  Belgium (595)  ·  Australia (576)  ·  Denmark (562)

Results publications

PMID 40576086, PMID 39356039, PMID 36005278, PMID 37160401, PMID 39704322, PMID 38299639, PMID 37146227, PMID 35224730, PMID 36791280, PMID 35018639, PMID 32734597, PMID 37916745, PMID 39513526, PMID 36416787, PMID 37888839, PMID 34778952, PMID 38770818, PMID 34519356, PMID 33107592, PMID 34184246, PMID 37068952, PMID 37811598, PMID 37947276, PMID 38682786, PMID 33314078, PMID 35224732, PMID 38018702, PMID 31401903, PMID 32390133, PMID 33586138, PMID 37870148, PMID 38189593, PMID 39963952, PMID 27238653, PMID 28410911, PMID 33783815, PMID 37651553, PMID 38724717, PMID 39878152, PMID 33283264, PMID 34164803, PMID 36472416, PMID 33782940, PMID 37528520, PMID 39607014, PMID 40337980, PMID 40465397, PMID 19941278, PMID 32588430, PMID 38864363

NIH funding

2023 (114), 2016 (77), 2017 (66), 2018 (61), 2019 (59), 2014 (53), 2025 (52), 2015 (51), 2009 (35), 2008 (32), U10CA180886 (22), P30CA033572 (21), U10CA032102 (18), P30CA043703 (17), 2005 (15)